Advertisement
Organisation › Details
Optibrium (Group)
Optibrium provides elegant software solutions for small molecule design, optimisation and data analysis. Optibrium’s lead product, StarDrop™, is a comprehensive suite of integrated software with a highly visual and user-friendly interface. StarDrop enables a seamless flow from the latest data through to predictive modelling and decision-making regarding the next round of synthesis and research, improving the speed, efficiency, and productivity of the discovery process. The company’s Augmented Chemistry® products and services, including Cerella™, deliver proven artificial intelligence technologies that continuously learn from all available data to supplement researchers’ experience and skills. Optibrium was founded in 2009 and is headquartered in Cambridge, UK, with a US subsidiary, Optibrium Inc., based in Cambridge MA. The company works closely with over 170 customers and collaborators worldwide, including leading global pharma, biotech, agrochemical and flavouring companies and not-for-profit and academic groups. *
Start | 2015-09-01 established | |
Today | Optibrium Inc. | |
Predecessor | Optibrium Ltd., US Office Cambridge | |
Industry | StarDrop™ software | |
Industry 2 | drug discovery software | |
Person | Segall, Matthew (Matt) (Optibrium 2009– CEO + co-founder before Inpharmatica/BioFocus) | |
Person 2 | Yemm, Stephen (Steve) (Optibrium 202301– Chief Commercial Officer before Paradigm4 + Aigenpulse + BioData + Vialis) | |
Region | Cambridge, Cambridgeshire | |
Country | United Kingdom (GB) | |
Street | Denny End Road Cambridge Innovation Park, F5-6 Blenheim House | |
City | CB25 9PB Cambridge, Cambridgeshire | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Optibrium Ltd.. (1/17/23). "Press Release: Optibrium Appoints Steve Yemm as Chief Commercial Officer". Cambridge. | ||
Record changed: 2023-01-17 |
Advertisement
More documents for Optibrium (Group)
- [1] Optibrium Ltd.. (8/31/23). "Press Release: Optibrium Acquires BioPharmics LLC, Expanding Its 3D Drug Design and Visualisation Offering". Cambridge....
- [2] Optibrium Ltd.. (1/17/23). "Press Release: Optibrium Appoints Steve Yemm as Chief Commercial Officer". Cambridge....
- [3] Intellegens Ltd.. (4/11/22). "Press Release: Predicting Pharmacokinetics with Optibrium and AstraZeneca"....
- [4] Optibrium Ltd.. (5/12/20). "Press Release: Optibrium Adopts Cheminformatics Toolkits From OpenEye Scientific". Cambridge & Santa Fe, NM....
- [5] Optibrium Ltd.. (2/17/20). "Press Release: Optibrium Appoints Dr Tim Hohm as Director of Commercial Strategy and Business Development". Cambridge....
- [6] Optibrium Ltd.. (1/28/19). "Press Release: Optibrium Strengthens Senior Management Team with Financial Director Appointment". Cambridge....
- [7] Medicines Discovery Catapult, The. (9/19/18). "Press Release: Novel Deep Learning Drug Discovery Platform Gets £1 Million Innovation boost. Optibrium, Intellegens and Medicines Discovery Catapult Awarded Funding to Apply Machine Learning in Drug Discover...
- [8] Optibrium Ltd.. (9/11/18). "Press Release: Optibrium and Intellegens Collaborate to Apply Novel Deep Learning Methods to Drug Discovery". Cambridge....
- [9] Optibrium Ltd.. (9/4/18). "Press Release: Optibrium and Enamine Collaboration Extends Commercial Compound Database Access for StarDrop Users". Cambridge & Kiev....
- [10] Optibrium Ltd.. (1/30/18). "Press Release: Optibrium Expands US and UK Operations". Cambridge....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top